PPARγ Agonists as Therapeutics for the Treatment of Alzheimer's Disease

Overview of attention for article published in Neurotherapeutics, July 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

patent: 25 patents

Citations

dimensions_citation: 227 Dimensions

Readers on

mendeley: 152 Mendeley

So far, Altmetric has seen 25 patents that reference this research output.

PPARγ Agonists as Therapeutics for the Treatment of Alzheimer's Disease

About this Attention Score

Mentioned by

Citations

Readers on

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of…

Grant US-11918569-B2

United States of America

Deuterium-enriched pioglitazone

Grant US-11918567-B2

United States of America

Methods of synthesizing enantiopure deuterium-enriched pioglitazone

Grant US-11767317-B1

United States of America

Crystalline forms of deuterium-enriched pioglitazone

Grant US-11319313-B2

United States of America

Compositions and methods for prophylaxis and treatment of addictions

Grant US-11241420-B2

United States of America

Methods and drug products for treating Alzheimer's disease

Grant US-11179375-B2

United States of America

Methods of treating neurological, metabolic, and other disorders using enantiopure…

Grant US-11141411-B2

United States of America

5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of…

Grant US-11123336-B2

United States of America

Disease risk factors and methods of use

Grant US-11021751-B2

United States of America

Deuterium-enriched pioglitazone

Grant US-10940143-B2

United States of America

Method of identifying disease risk factors

Grant US-10865449-B2

United States of America

Deuterium-enriched pioglitazone

Grant US-10576071-B2

United States of America

Methods of treating neurological, metabolic, and other disorders using enantiopure…

Grant US-10188639-B2

United States of America

COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF ADDICTIONS

Application EP-3398599-A1

European Patent Office

Compositions and methods for prophylaxis and treatment of addictions

Grant US-10064850-B2

United States of America

Methods and drug products for treating alzheimer's disease

Grant US-9724339-B2

United States of America

Methods and drug products for treating Alzheimer's disease

Grant US-9102666-B2

United States of America

METHOD OF IDENTIFYING DISEASE RISK FACTORS

Application EA-021399-B1

Eurasian Patent Organisation

Disease risk factors and methods of use

Grant US-8846315-B2

United States of America

Method of identifying disease risk factors

Grant US-8815508-B2

United States of America

Compositions and methods for prophylaxis and treatment of addictions

Grant US-8426439-B2

United States of America

METHOD FOR TREATMENT OF DISEASES CAUSED BY ACCUMULATION OF BETA-AMYLOIDS IN BRAIN…

Application WO-2013022139-A1

World Intellectual Property Organisation (WIPO)

COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF ADDICTIONS

Application WO-2010105103-A1

World Intellectual Property Organisation (WIPO)

Use of pyrrolopyridine compounds for activating PPAR receptors and treatment of…

Grant US-7728002-B2

United States of America

Pyrrolopyridine compounds, method of making them and uses thereof

Grant US-7557122-B2

United States of America